Kwality Pharmaceuticals Ltd (KWAL)

Currency in INR
1,457.25
+36.00(+2.53%)
Delayed Data·
KWAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,362.001,470.00
52 wk Range
596.051,572.00
Key Statistics
Bid/Ask
1,457.50 / 1,463.95
Prev. Close
1,421.25
Open
1,410
Day's Range
1,362-1,470
52 wk Range
596.05-1,572
Volume
34.76K
Average Volume (3m)
23.01K
1-Year Change
105.7681%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KWAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Kwality Pharmaceuticals Ltd Company Profile

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.

Employees
997
Market
India

Compare KWAL to Peers and Sector

Metrics to compare
KWAL
Peers
Sector
Relationship
P/E Ratio
26.2x27.7x−0.5x
PEG Ratio
0.300.270.00
Price/Book
5.1x3.4x2.6x
Price / LTM Sales
3.2x2.9x3.3x
Upside (Analyst Target)
-9.0%47.0%
Fair Value Upside
Unlock2.1%5.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 12, 2026
EPS / Forecast
15.42 / --
Revenue / Forecast
1.24B / --
EPS Revisions
Last 90 days

KWAL Income Statement

People Also Watch

1,285.20
SILT
+1.23%
1,608.65
3BBL
+1.42%
1,417.00
MOBA
+3.87%

FAQ

What Is the Kwality Pharma (KWAL) Stock Price Today?

The Kwality Pharma stock price today is 1,457.25

What Stock Exchange Does Kwality Pharma Trade On?

Kwality Pharma is listed and trades on the Bombay Stock Exchange.

What Is the Stock Symbol for Kwality Pharma?

The stock symbol for Kwality Pharma is "KWAL."

What Is the Kwality Pharma Market Cap?

As of today, Kwality Pharma market cap is 15.13B.

What Is Kwality Pharma's Earnings Per Share (TTM)?

The Kwality Pharma EPS (TTM) is 54.42.

From a Technical Analysis Perspective, Is KWAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kwality Pharma Stock Split?

Kwality Pharma has split 1 times.

How Many Employees Does Kwality Pharma Have?

Kwality Pharma has 997 employees.

What is the current trading status of Kwality Pharma (KWAL)?

As of Feb 17, 2026, Kwality Pharma (KWAL) is trading at a price of 1,457.25, with a previous close of 1,421.25. The stock has fluctuated within a day range of 1,362.00 to 1,470.00, while its 52-week range spans from 596.05 to 1,572.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.